Investigating how small molecules can improve healing of diabetic wounds
Mechanistic study of Small-molecular Therapy in diabetic Wound Healing
This study is looking at how two natural compounds, Trans-resveratrol and hesperetin, might help heal wounds better for people with diabetes by improving the growth of new blood vessels, which is really important for healing diabetic foot ulcers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-10791784 on NIH RePORTER |
What this research studies
This research focuses on understanding how two dietary compounds, Trans-resveratrol and hesperetin, can enhance wound healing in diabetic patients. By studying their effects on endothelial cells, which are crucial for forming new blood vessels, the research aims to uncover the molecular mechanisms that improve healing processes. The project will explore how these compounds influence gene expression and the production of factors that promote angiogenesis, which is vital for repairing diabetic foot ulcers. The ultimate goal is to develop effective treatments that can reduce amputation rates among diabetic patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who are experiencing foot ulcers or are at risk of developing them.
Not a fit: Patients without diabetes or those who do not have any issues related to wound healing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve wound healing in diabetic patients, potentially reducing the need for amputations.
How similar studies have performed: Previous research has shown promising results with similar dietary compounds in improving wound healing, indicating potential for success in this approach.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Yi, Zhengping — Wayne State University
- Study coordinator: Yi, Zhengping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.